Informa

第三天 -

第三天 -

search
8:00am - 8:10am
报名・咖啡时光
主题演讲
Showing 1 of 1 Streams
8:10am - 8:15am
主席致词
8:15am - 8:45am
用编码mRNA的干扰素lambda调节呼吸道中的宿主免疫力
  • Christian Plank, PhD - Chief Technology Officer, Ethris GmbH
8:45am - 9:15am
mRNA 分析策略
  • Simon Klenk, PhD - Director RNA Analytics, RNA Biochemistry, BioNTech SE
9:15am - 9:45am
针对每个 mRNA 序列微调基于 PCR 的 mRNA 制造平台
  • Aditi Mehta, PhD - Associate Director, Head of mRNA Process & Deliver, Merck KGaA
9:45am - 10:15am
实现基于 mRNA 疗法临床开发的脂质奈米粒子
  • Ying Tam, Ph.D. - Chief Scientific Officer, Acuitas Therapeutics
10:15am - 10:55am
交流/咖啡时光、观赏海报和展览
同期会议主题
Showing 2 of 2 Streams
10:55am - 11:00am
主席致词
11:00am - 11:30am
STK-002 的临床前数据，一种正在开发用于治疗常染色体显性视神经萎缩 (ADOA) 的反义寡核苷酸
  • Shobha Ravipaty, PhD - Director, Stoke Therapeutics
11:30am - 12:00pm
寡核苷酸疗法的发现与递送
  • Jayaprakash Nair, PhD - Vice President, Research, Chemistry and Delivery Science, Alnylam Pharmaceuticals
12:00pm - 12:30pm
从实验室到临床：开发用于难治性癌症患者免疫治疗的 GalXC-Plus siRNA 和 DCR-STAT3
  • Jennifer Lockridge, PhD - VP, Dicerna TRU Early Development, Novo Nordisk
10:55am - 11:00am
主席致词
11:00am - 11:30am
用于穿越血脑屏障递送治疗性 RNA 之以蛋白质为基础的奈米胶囊
  • Ekkehard Leberer, PhD - Scientific Advisor, Neuway Pharma
11:30am - 12:00pm
利用组织标靶脂质奈米粒子 (ttLNP) 平台重新定义新型基因组药物的非病毒递送
  • Kate Zhang, Ph.D. - Chief Scientific Officer, Hopewell Therapeutics
12:00pm - 12:30pm
调整脂质奈米粒子以适应特定应用
  • Ed Yaworski - Chief Technology Officer, Genevant Sciences Corp
12:30pm - 1:40pm
交流・午餐会、观赏海报和展览
Showing 2 of 2 Streams
1:40pm - 1:45pm
主席致词
1:45pm - 2:15pm
用于治疗癌症的标靶免疫抑制肿瘤微环境之反义寡核苷酸案例
  • Frank Jaschinski, Ph.D. - Chief Scientific Officer, Secarna Pharmaceuticals
2:15pm - 2:45pm
CIVI 008：一种针对 PCSK9 的口服活性 LNA 药物
  • Henrik Oerum, PhD - Founder and Chief Scientific Officer, CiVi Biopharma Inc.
2:45pm - 3:15pm
TTX-MC138 的开发，一种针对多原发转移癌的首创 miRNA-10b 标靶疗法
  • Zdravka Medarova, PhD - Founder and Chief Technology Officer, TransCode Therapeutics
1:40pm - 1:45pm
主席致词
1:45pm - 2:15pm
Gate2Brain Shuttles：除了运输小分子之外的作用
  • Meritxell Teixido, PhD - CEO and CSO, Gate2Brain
2:15pm - 2:45pm
为高效、安全的大规模胜肽生产制程制定控制策略
  • El Djouhar Rekai, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
2:45pm - 3:15pm
胜肽/核苷酸合成中整合流动化学的线上监测方法
  • Pengyu Xu, Ph.D. - President and Representative Director, SynCrest Inc.
3:15pm - 3:45pm
交流/咖啡时光、观赏海报和展览
Showing 2 of 2 Streams
3:45pm - 4:15pm
使用含有 PN 的嵌合寡核苷酸在临床前模型中为患有杜氏肌肉营养不良症的男孩创建外显子跳跃疗法
  • Elizabeth Wagner, Ph.D. - Director, Biology, Wave Life Sciences
4:15pm - 4:45pm
IND 申请中精心设计的非临床部分的构成要素
  • Emily Place, PhD - Senior Consultant Nonclinical, Biologics Consulting
4:45pm - 5:15pm
GalAhead™：下调单一/多个基因的 RNAi 治疗平台
  • Jimmy Weterings, PhD - Senior Director, Head of Technology Development, Sirnaomics
3:45pm - 4:15pm
胜肽CMC策略
  • Stephane Varray, PhD - Director, Global Peptides Platform, CordenPharma International
4:15pm - 4:45pm
绿色生产胺基酸的生物催化剂
  • Christina Boville, PhD - Co-founder & CEO, Aralez Bio
4:45pm - 5:15pm
个体化癌症疫苗：发展高通量 cGMP 生产概念
  • Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
5:15pm - 5:20pm
会议结束
第二天

* 活动内容有可能不事先告知作更动及调整。